$38.02
0.862.31%
At Close: -
$38.37
0.350.92%
After Hours: 6:25 PM EDT
15 minutes delayed
Comments
Loading...
Dutch Bros
BROSNYSE
Unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Dutch Bros (NYSE:BROS) Stock, Analyst Ratings, Price Targets, Forecasts
Dutch Bros Inc has a consensus price target of $42.07 based on the ratings of 15 analysts. The high is $64 issued by Gordon Haskett on April 13, 2022. The low is $28 issued by UBS on September 21, 2023. The 3 most-recent analyst ratings were released by Guggenheim, Baird, and TD Cowen on July 11, 2024, July 3, 2024, and June 18, 2024, respectively. With an average price target of $42.67 between Guggenheim, Baird, and TD Cowen, there's an implied 11.20% upside for Dutch Bros Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Guggenheim
Baird
TD Cowen
B of A Securities
JP Morgan
1calculated from analyst ratings
Analyst Ratings for Dutch Bros
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 07/11/2024 | Buy Now | -6.18% | Guggenheim | Gregory Francfort | $30 → $36 | Maintains | Neutral | Get Alert |
| 07/03/2024 | Buy Now | 9.46% | Baird | David Tarantino | — | Maintains | Neutral | Get Alert |
| 06/18/2024 | Buy Now | 30.31% | TD Cowen | Andrew Charles | $50 → $50 | Reiterates | Buy → Buy | Get Alert |
| 06/13/2024 | Buy Now | 30.31% | TD Cowen | Andrew Charles | $46 → $50 | Maintains | Buy | Get Alert |
| 06/10/2024 | Buy Now | 27.7% | B of A Securities | Sara Senatore | $44 → $49 | Maintains | Buy | Get Alert |
| 06/05/2024 | Buy Now | 19.89% | TD Cowen | Andrew Charles | $46 → $46 | Reiterates | Buy → Buy | Get Alert |
| 06/03/2024 | Buy Now | 14.67% | JP Morgan | John Ivankoe | $40 → $44 | Maintains | Overweight | Get Alert |
| 05/16/2024 | Buy Now | 17.28% | Wedbush | Nick Setyan | $39 → $45 | Maintains | Outperform | Get Alert |
| 05/10/2024 | Buy Now | 19.89% | TD Cowen | Andrew Charles | $33 → $46 | Upgrade | Hold → Buy | Get Alert |
| 05/08/2024 | Buy Now | -8.78% | Barclays | Jeffrey Bernstein | $30 → $35 | Maintains | Equal-Weight | Get Alert |
| 05/08/2024 | Buy Now | 1.64% | Wedbush | Nick Setyan | $37 → $39 | Maintains | Outperform | Get Alert |
| 04/26/2024 | Buy Now | -14% | TD Cowen | Andrew Charles | → $33 | Reiterates | Hold → Hold | Get Alert |
| 04/12/2024 | Buy Now | -14% | TD Cowen | Andrew Charles | → $33 | Reiterates | Hold → Hold | Get Alert |
| 04/11/2024 | Buy Now | -14% | TD Cowen | Andrew Charles | → $33 | Reiterates | Hold → Hold | Get Alert |
| 04/10/2024 | Buy Now | -3.57% | Wedbush | Nick Setyan | → $37 | Reiterates | Outperform → Outperform | Get Alert |
| 04/10/2024 | Buy Now | -14% | TD Cowen | Andrew Charles | → $33 | Reiterates | Hold → Hold | Get Alert |
| 04/05/2024 | Buy Now | -21.81% | Guggenheim | Gregory Francfort | → $30 | Reiterates | Neutral → Neutral | Get Alert |
| 04/03/2024 | Buy Now | -3.57% | Wedbush | Nick Setyan | → $37 | Reiterates | Outperform → Outperform | Get Alert |
| 04/03/2024 | Buy Now | 4.25% | Stifel | Chris O'Cull | $40 → $40 | Maintains | Buy | Get Alert |
| 03/19/2024 | Buy Now | 4.25% | JP Morgan | John Ivankoe | $34 → $40 | Maintains | Overweight | Get Alert |
| 03/04/2024 | Buy Now | -3.57% | Piper Sandler | Brian Mullan | $32 → $37 | Upgrade | Neutral → Overweight | Get Alert |
| 02/22/2024 | Buy Now | -21.81% | Barclays | Jeffrey Bernstein | $31 → $30 | Maintains | Equal-Weight | Get Alert |
| 02/22/2024 | Buy Now | -14% | TD Cowen | Andrew Charles | → $33 | Reiterates | Market Perform → Market Perform | Get Alert |
| 02/22/2024 | Buy Now | -3.57% | Wedbush | Nick Setyan | → $37 | Reiterates | Outperform → Outperform | Get Alert |
| 01/16/2024 | Buy Now | -8.78% | Stifel | Chris O'Cull | $32 → $35 | Upgrade | Hold → Buy | Get Alert |
| 01/03/2024 | Buy Now | -19.21% | Barclays | Jeffrey Bernstein | $28 → $31 | Maintains | Equal-Weight | Get Alert |
| 12/21/2023 | Buy Now | -3.57% | Wedbush | Nick Setyan | $35 → $37 | Maintains | Outperform | Get Alert |
| 11/20/2023 | Buy Now | -8.78% | JP Morgan | John Ivankoe | $30 → $35 | Upgrade | Neutral → Overweight | Get Alert |
| 11/08/2023 | Buy Now | -8.78% | Wedbush | Nick Setyan | $31 → $35 | Maintains | Outperform | Get Alert |
| 11/03/2023 | Buy Now | -19.21% | Wedbush | Nick Setyan | $37 → $31 | Maintains | Outperform | Get Alert |
| 10/23/2023 | Buy Now | -32.24% | Barclays | Jeffrey Bernstein | $30 → $26 | Maintains | Equal-Weight | Get Alert |
| 09/21/2023 | Buy Now | -27.03% | UBS | Dennis Geiger | → $28 | Initiates | → Neutral | Get Alert |
| 09/11/2023 | Buy Now | -16.6% | Stifel | Chris O'Cull | $36 → $32 | Maintains | Hold | Get Alert |
| 08/23/2023 | Buy Now | -14% | Piper Sandler | Aisling Grueninger | $30 → $33 | Maintains | Neutral | Get Alert |
| 08/09/2023 | Buy Now | -3.57% | Wedbush | Nick Setyan | → $37 | Reiterates | Outperform → Outperform | Get Alert |
| 06/15/2023 | Buy Now | -14% | TD Cowen | Andrew Charles | → $33 | Reiterates | Market Perform → Market Perform | Get Alert |
| 06/14/2023 | Buy Now | -21.81% | Piper Sandler | Aisling Grueninger | → $30 | Assumes | → Neutral | Get Alert |
| 05/15/2023 | Buy Now | -3.57% | Wedbush | Nick Setyan | → $37 | Reiterates | Outperform → Outperform | Get Alert |
| 05/10/2023 | Buy Now | -16.6% | JP Morgan | John Ivankoe | $38 → $32 | Downgrade | Overweight → Neutral | Get Alert |
| 05/10/2023 | Buy Now | -3.57% | Wedbush | Nick Setyan | → $37 | Reiterates | → Outperform | Get Alert |
| 05/10/2023 | Buy Now | -14% | TD Cowen | Andrew Charles | $39 → $33 | Downgrade | Outperform → Market Perform | Get Alert |
| 04/05/2023 | Buy Now | -3.57% | Wedbush | Nick Setyan | → $37 | Upgrade | Neutral → Outperform | Get Alert |
| 04/04/2023 | Buy Now | -6.18% | Stifel | Chris O'Cull | $37 → $36 | Maintains | Hold | Get Alert |
| 02/23/2023 | Buy Now | -3.57% | Wedbush | Nick Setyan | → $37 | Reiterates | → Neutral | Get Alert |
| 02/23/2023 | Buy Now | 12.07% | Cowen & Co. | Andrew Charles | → $43 | Reiterates | → Outperform | Get Alert |
| 02/16/2023 | Buy Now | -3.57% | Guggenheim | Gregory Francfort | → $37 | Initiates | → Neutral | Get Alert |
| 01/26/2023 | Buy Now | -19.21% | Barclays | Jeffrey Bernstein | $29 → $31 | Maintains | Equal-Weight | Get Alert |
| 01/25/2023 | Buy Now | -3.57% | Wedbush | Nick Setyan | → $37 | Initiates | → Neutral | Get Alert |
| 01/05/2023 | Buy Now | -24.42% | Barclays | Jeffrey Bernstein | $30 → $29 | Maintains | Equal-Weight | Get Alert |
| 11/10/2022 | Buy Now | -16.6% | Piper Sandler | Nicole Miller Regan | $40 → $32 | Maintains | Overweight | Get Alert |
| 11/10/2022 | Buy Now | 12.07% | Cowen & Co. | Andrew Charles | $53 → $43 | Maintains | Outperform | Get Alert |
| 10/20/2022 | Buy Now | -19.21% | Barclays | Jeffrey Bernstein | $37 → $31 | Maintains | Equal-Weight | Get Alert |
| 10/12/2022 | Buy Now | — | JP Morgan | John Ivankoe | — | Upgrade | Neutral → Overweight | Get Alert |
| 10/05/2022 | Buy Now | 4.25% | Piper Sandler | Nicole Miller Regan | $50 → $40 | Maintains | Overweight | Get Alert |
| 08/11/2022 | Buy Now | -3.57% | Barclays | Jeffrey Bernstein | $34 → $37 | Maintains | Equal-Weight | Get Alert |
| 08/11/2022 | Buy Now | 30.31% | Piper Sandler | Nicole Miller Regan | $44 → $50 | Maintains | Overweight | Get Alert |
| 07/11/2022 | Buy Now | — | Baird | David Tarantino | — | Downgrade | Outperform → Neutral | Get Alert |
| 06/09/2022 | Buy Now | -11.39% | Barclays | Jeffrey Bernstein | $25 → $34 | Maintains | Equal-Weight | Get Alert |
| 06/08/2022 | Buy Now | 4.25% | JP Morgan | John Ivankoe | → $40 | Downgrade | Overweight → Neutral | Get Alert |
| 05/13/2022 | Buy Now | -34.84% | Barclays | Jeffrey Bernstein | $53 → $25 | Maintains | Equal-Weight | Get Alert |
| 05/12/2022 | Buy Now | -21.81% | Baird | David Tarantino | $60 → $30 | Maintains | Outperform | Get Alert |
| 05/12/2022 | Buy Now | 14.67% | Piper Sandler | Nicole Miller Regan | $75 → $44 | Maintains | Overweight | Get Alert |
| 05/12/2022 | Buy Now | -8.78% | Cowen & Co. | Andrew Charles | $65 → $35 | Maintains | Outperform | Get Alert |
| 05/12/2022 | Buy Now | -21.81% | Stifel | Chris O'Cull | $70 → $30 | Downgrade | Buy → Hold | Get Alert |
| 04/13/2022 | Buy Now | 66.8% | Gordon Haskett | Jeff Farmer | → $64 | Initiates | → Buy | Get Alert |
| 04/05/2022 | Buy Now | 95.47% | Piper Sandler | Nicole Miller Regan | $85 → $75 | Maintains | Overweight | Get Alert |
| 12/15/2021 | Buy Now | 38.13% | Barclays | — | — | Maintains | Equal-Weight | Get Alert |
| 11/11/2021 | Buy Now | 82.43% | Cowen & Co. | Andrew Charles | — | Maintains | Outperform | Get Alert |
| 10/11/2021 | Buy Now | 22.49% | JP Morgan | John Ivankoe | — | Initiates | → Overweight | Get Alert |
| 10/11/2021 | Buy Now | 4.25% | Barclays | Jeffrey Bernstein | — | Initiates | → Equal-Weight | Get Alert |
| 10/11/2021 | Buy Now | 56.37% | Piper Sandler | Nicole Miller Regan | — | Initiates | → Overweight | Get Alert |
| 10/11/2021 | Buy Now | 45.95% | Baird | David Tarantino | — | Initiates | → Outperform | Get Alert |
| 10/11/2021 | Buy Now | 43.34% | B of A Securities | Sara Senatore | — | Initiates | → Buy | Get Alert |
| 10/11/2021 | Buy Now | 30.31% | Cowen & Co. | Andrew Charles | — | Initiates | → Outperform | Get Alert |
FAQ
What is the target price for Dutch Bros (BROS) stock?
The latest price target for Dutch Bros (NYSE:BROS) was reported by Guggenheim on July 11, 2024. The analyst firm set a price target for $36.00 expecting BROS to fall to within 12 months (a possible -6.18% downside). 35 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Dutch Bros (BROS)?
The latest analyst rating for Dutch Bros (NYSE:BROS) was provided by Guggenheim, and Dutch Bros maintained their neutral rating.
When was the last upgrade for Dutch Bros (BROS)?
The last upgrade for Dutch Bros Inc happened on May 10, 2024 when TD Cowen raised their price target to $46. TD Cowen previously had a hold for Dutch Bros Inc.
When was the last downgrade for Dutch Bros (BROS)?
The last downgrade for Dutch Bros Inc happened on May 10, 2023 when JP Morgan changed their price target from $38 to $32 for Dutch Bros Inc.
When is the next analyst rating going to be posted or updated for Dutch Bros (BROS)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Dutch Bros, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Dutch Bros was filed on July 11, 2024 so you should expect the next rating to be made available sometime around July 11, 2025.
Is the Analyst Rating Dutch Bros (BROS) correct?
While ratings are subjective and will change, the latest Dutch Bros (BROS) rating was a maintained with a price target of $30.00 to $36.00. The current price Dutch Bros (BROS) is trading at is $38.37, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.